Engineering Commons^™

Retrospective Implementation Of Quality By Design For Legacy Commercialized Enzyme Replacement Therapies, Anup Agarwal, Eric Hayduk

Cell Culture Engineering XV

Quality by Design (QbD) has been widely adopted by the pharmaceutical industry as a tool for transforming development, manufacture, and commercialization of drug products. QbD ensures that quality is built into a manufacturing process to consistently produce desired product. As per a FDA guidance¹, QbD should be employed at the product development stage to ensure manufacture of a product with predefined quality. Here we present a retrospective QbD approach employed at Shire to define an improved control strategy for a commercial process using risk-based process understanding and characterization. Key challenges and considerations of implementing a QbD strategy on …

Building Qbd Frameworks Retrospectively For Commercial Products And The Use Of Scale-Down Model Qualification Strategies To Support Continuous Improvement, Jose Menezes, Francisca Gouveia, Pedro Felizardo

Cell Culture Engineering XV

A science-based justification for many continuous improvement and post-approval submissions on ‘legacy products’ (i.e., commercial products developed without a QbD rationale) requires that some of those missing QbD elements in the original filing, be defined retrospectively.

Here we present a new proposal to achieve that, that is general and very capable of supporting the transition of ‘legacy’ non-QbD into quasi-QbD filings. It is based on (1) a formal criticality analysis to the current process version to support the choice of quality attributes and process parameters in the filing, and identification of additional ones that may impact the quality target-product profile …

Michael Borys (Bristol- Myers Squibb) Incorporation Of Qbd Elements Into The Development And Characterization Of A Second Generation Process, Michael Borys, Nicholas Abu-Absi

Cell Culture Engineering XV

QbD principles are readily incorporated into mammalian cell processes to streamline process development and characterization. A key enabler of the implementation of these principles has been widespread adoption of platform technologies by the industry. This allows easy and efficient navigation of the QbD roadmap laid out in the A-Mab case study over the course of the development lifecycle of a product.

Here we examine the case of a 2nd generation process for a legacy product that was originally developed and approved using the traditional approach to process development and characterization. The goal of the 2nd generation process was to achieve …

A Quality By Design (Qbd) Approach To Cell Culture Process Characterization, Melissa Mun

Cell Culture Engineering XV

Quality by Design (QbD) is a science- and risk-based approach to development that begins with predefined objectives and emphasizes product and process understanding as well as process control. This case study will describe a QbD approach to characterizing a monoclonal antibody (MAb) cell culture process. Process parameters to study were selected through a risk ranking and filtering assessment based on historical development data, manufacturing history, and scientific understanding. Statistically designed, multifactor process characterization studies were performed in scale-down bioreactors to build understanding of parameter impacts on critical quality attributes (CQAs) and key performance indicators (KPIs). Production culture process characterization studies, …